Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An announcement from Belluscura PLC ( (GB:BELL) ) is now available.
Belluscura PLC has announced its intention to appoint an administrator following unsuccessful refinancing discussions with the Omaha Investor Group. The company’s US subsidiary, Belluscura LLC, has filed for Chapter 7 Bankruptcy, leading to a default on convertible loan notes amounting to £9.17m, which the company cannot repay. Consequently, Belluscura’s Nominated Adviser, SPARK Advisory Partners Limited, has resigned, and the company does not plan to appoint a replacement, risking the cancellation of its AIM trading admission.
More about Belluscura PLC
Belluscura PLC is a UK-based medical device company that specializes in developing oxygen enrichment technology for various industries and therapies.
Technical Sentiment Signal: Strong Sell
Current Market Cap: £3.01M
For an in-depth examination of BELL stock, go to TipRanks’ Overview page.